STOCK TITAN

Integra Lifesciences Hldgs Cp reported $1.6B in revenue and a $516.8M net loss for fiscal 2025. See the full IART financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

Integra LifeSciences will webcast management presentations at the 2026 Wells Fargo and Morgan Stanley healthcare conferences for investors to follow live online.

(Neutral)
(Neutral)
Tags

Integra LifeSciences (IART) will present at the 2026 Wells Fargo Healthcare Conference on September 9, 2026, at 2:15 p.m. ET, and at the 2026 Morgan Stanley Healthcare Conference on September 15, 2026, at 4:05 p.m. ET.

Presenters include the chief financial officer, chief commercial officer, and the chairman and chief executive officer. A live webcast of both presentations will be accessible through the company’s investor relations website under Events & Presentations.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

The prior conference-presentation announcement produced a -1.74% 24-hour reaction on June 15. That c...
Analysis

The prior conference-presentation announcement produced a -1.74% 24-hour reaction on June 15. That comparator frames this notice as communication rather than reported operating results; the effective S-3ASR shelf is a financing risk to monitor.

Key Figures

Wells Fargo presentation date: September 9, 2026 Wells Fargo presentation time: 2:15 p.m. ET Morgan Stanley presentation date: September 15, 2026 +1 more
4 metrics
Wells Fargo presentation date September 9, 2026 2026 Wells Fargo Healthcare Conference
Wells Fargo presentation time 2:15 p.m. ET September 9, 2026
Morgan Stanley presentation date September 15, 2026 2026 Morgan Stanley Healthcare Conference
Morgan Stanley presentation time 4:05 p.m. ET September 15, 2026

Historical Context

5 past events · Latest: Jul 29 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 29 Second-quarter earnings Positive -16.6% Returned to profitability and reaffirmed full-year adjusted EPS guidance
Jul 16 Earnings call scheduling Neutral +5.7% Scheduled second-quarter results release and conference call
Jul 02 Regulatory appointment Positive +0.9% Appointed Topaz Kirlew as corporate chief regulatory officer
Jun 23 Executive appointments Positive +0.5% Announced commercial leadership appointments across two business segments
Jun 15 Conference presentation Neutral -1.7% Announced presentation at the Truist Securities MedTech Conference

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The stock diverged on the July 29 earnings release and June 15 conference notice, while leadership appointments were followed by modest gains.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Stuart Essig, chairman and chief executive officer, will present at the 2026 Morgan Stanley Healthcare Conference on Tuesday, September 15, 2026, at 4:05 p.m. ET.

A live webcast of the presentations will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 


Integra LifeSciences Holdings Corporation


FAQ

When will Integra LifeSciences (IART) present at the 2026 Wells Fargo Healthcare Conference?

Integra LifeSciences is scheduled to present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. The presentation will feature chief financial officer Lea Knight and chief commercial officer Michael McBreen.

When is Integra LifeSciences (IART) presenting at the 2026 Morgan Stanley Healthcare Conference?

Integra LifeSciences will present at the 2026 Morgan Stanley Healthcare Conference on Tuesday, September 15, 2026, at 4:05 p.m. ET. The presentation will be given by chairman and chief executive officer Stuart Essig.

How can investors access the Integra LifeSciences (IART) webcasts for the 2026 healthcare conferences?

A live webcast of both Integra LifeSciences presentations will be available on the company’s investor relations website under the Events & Presentations section. Investors can stream the events online at the scheduled times.

Who from Integra LifeSciences (IART) is speaking at the 2026 Wells Fargo and Morgan Stanley healthcare conferences?

At the Wells Fargo conference, Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present. At the Morgan Stanley conference, Stuart Essig, chairman and chief executive officer, will deliver the presentation.